KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Globus Medical (GMED) EBIAT (2016 - 2025)

Historic EBIAT for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $119.0 million.

  • Globus Medical's EBIAT rose 12950.46% to $119.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $423.8 million, marking a year-over-year increase of 36308.07%. This contributed to the annual value of $103.0 million for FY2024, which is 1618.66% down from last year.
  • Globus Medical's EBIAT amounted to $119.0 million in Q3 2025, which was up 12950.46% from $202.8 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's EBIAT registered a high of $202.8 million during Q2 2025, and its lowest value of -$7.1 million during Q1 2024.
  • Over the past 5 years, Globus Medical's median EBIAT value was $47.2 million (recorded in 2021), while the average stood at $50.7 million.
  • Over the last 5 years, Globus Medical's EBIAT had its largest YoY gain of 509398.8% in 2024, and its largest YoY loss of 11448.64% in 2024.
  • Quarter analysis of 5 years shows Globus Medical's EBIAT stood at $15.1 million in 2021, then soared by 231.42% to $50.1 million in 2022, then plummeted by 69.97% to $15.0 million in 2023, then soared by 76.3% to $26.5 million in 2024, then soared by 348.84% to $119.0 million in 2025.
  • Its EBIAT was $119.0 million in Q3 2025, compared to $202.8 million in Q2 2025 and $75.5 million in Q1 2025.